{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:36:16Z","timestamp":1793068576721,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science Committee of RA","award":["24FP-3A057"],"award-info":[{"award-number":["24FP-3A057"]}]},{"name":"Science Committee of RA","award":["24FP-3A057"],"award-info":[{"award-number":["24FP-3A057"]}]},{"name":"Science Committee of RA","award":["24FP-3A057"],"award-info":[{"award-number":["24FP-3A057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23237-y","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:38:38Z","timestamp":1762972718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In silico and in vitro evaluation of drug-like properties and anticancer potential of novel 5-fluorouracil derivatives"],"prefix":"10.1038","volume":"15","author":[{"given":"Kristine","family":"Harutyunyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Nersesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Ayvazyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmi","family":"Avagyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merirouz","family":"Melkumyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Sargsyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepan","family":"Tatikyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaven","family":"Karalyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hranush","family":"Avagyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Harutyunyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gohar","family":"Tsakanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Babayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"23237_CR1","doi-asserted-by":"publisher","first-page":"100075","DOI":"10.1016\/j.medidd.2020.100075","volume":"9","author":"FD Makurvet","year":"2021","unstructured":"Makurvet, F. D. Biologics vs. small molecules: drug costs and patient access. Med. Drug Discov. 9, 100075. https:\/\/doi.org\/10.1016\/j.medidd.2020.100075 (2021).","journal-title":"Med. Drug Discov"},{"key":"23237_CR2","doi-asserted-by":"publisher","first-page":"103845","DOI":"10.1016\/j.drudis.2023.103845","volume":"29","author":"A Acharya","year":"2024","unstructured":"Acharya, A., Yadav, M., Nagpure, M., Kumaresan, S. & Guchhait, S. K. Molecular medicinal insights into scaffold hopping-based drug discovery success. Drug Discov Today. 29, 103845. https:\/\/doi.org\/10.1016\/j.drudis.2023.103845 (2024).","journal-title":"Drug Discov Today"},{"key":"23237_CR3","first-page":"663","volume":"179","author":"C Heidelberger","year":"1957","unstructured":"Heidelberger, C., Chaudhuri, N. K., Danneberg, P., Mooren, D. & Griesbach, L. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nat. Publ Group. 179, 663\u2013666 (1957).","journal-title":"Nat. Publ Group."},{"key":"23237_CR4","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.3390\/ijms25137470","volume":"25","author":"M Barathan","year":"2024","unstructured":"Barathan, M. et al. Innovative strategies to combat 5-fluorouracil resistance in colorectal cancer: the role of phytochemicals and extracellular vesicles. Int. J. Mol. Sci. 25, 7470. https:\/\/doi.org\/10.3390\/ijms25137470 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"23237_CR5","doi-asserted-by":"publisher","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy, C. & Kundu, C. N. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair Inhibition. Biomed. Pharmacother. 137, 111285. https:\/\/doi.org\/10.1016\/j.biopha.2021.111285 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"23237_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley, D. B., Harkin, D. P. & Johnston, P. G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330\u2013338. https:\/\/doi.org\/10.1038\/nrc1074 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"23237_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail, M., Jiang, C. H. & Li, N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol. Cancer. 23, 203. https:\/\/doi.org\/10.1186\/s12943-024-02119-3 (2024).","journal-title":"Mol. Cancer"},{"key":"23237_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.20517\/cdr.2022.136","volume":"6","author":"WH Gmeiner","year":"2023","unstructured":"Gmeiner, W. H. & Okechukwu, C. C. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist. 6, 257\u2013272 (2023).","journal-title":"Cancer Drug Resist."},{"issue":"2","key":"23237_CR9","doi-asserted-by":"publisher","first-page":"e0115686","DOI":"10.1371\/journal.pone.0115686","volume":"10","author":"C Focaccetti","year":"2015","unstructured":"Focaccetti, C. et al. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy, and ROS production in endothelial cells and cardiomyocytes. PLoS One. 10 (2), e0115686. https:\/\/doi.org\/10.1371\/journal.pone.0115686 (2015).","journal-title":"PLoS One"},{"key":"23237_CR10","doi-asserted-by":"publisher","first-page":"e63177","DOI":"10.1371\/journal.pone.0063177","volume":"8","author":"M Filgueiras","year":"2013","unstructured":"Filgueiras, M., Morrot, A., Soares, P., Costa, M. & Mermelstein, C. Effects of 5-fluorouracil in nuclear and cellular morphology, proliferation, cell cycle, apoptosis, cytoskeletal and caveolar distribution in primary cultures of smooth muscle cells. PLoS One. 8, e63177. https:\/\/doi.org\/10.1371\/journal.pone.0063177 (2013).","journal-title":"PLoS One"},{"key":"23237_CR11","first-page":"23","volume":"1","author":"M Shanker","year":"2010","unstructured":"Shanker, M., Willcutts, D., Roth, J. A. & Ramesh, R. Drug resistance in lung cancer. Lung Cancer. 1, 23\u201336 (2010).","journal-title":"Lung Cancer"},{"key":"23237_CR12","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.1007\/s13277-014-2543-3","volume":"35","author":"JG Zhao","year":"2014","unstructured":"Zhao, J. G., Ren, K. M. & Tang, J. Overcoming 5-FU resistance in human non-small cell lung cancer cells by the combination of 5-FU and cisplatin through the Inhibition of glucose metabolism. Tumour Biol. 35, 12305\u201312315. https:\/\/doi.org\/10.1007\/s13277-014-2543-3 (2014).","journal-title":"Tumour Biol."},{"key":"23237_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11094-013-0948-8","volume":"47","author":"AA Arutyunyan","year":"2013","unstructured":"Arutyunyan, A. A., Mamyan, S. S., Stepanyan, H. M. & Paronikyan, R. V. Synthesis and antitumor and antibacterial properties of new n-alkylated pyrimidines. Pharm. Chem. J. 47, 303\u2013306. https:\/\/doi.org\/10.1007\/s11094-013-0948-8 (2013).","journal-title":"Pharm. Chem. J."},{"issue":"9","key":"23237_CR14","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1134\/S1070428023090087","volume":"59","author":"AA Harutyunyan","year":"2023","unstructured":"Harutyunyan, A. A. et al. Synthesis, molecular docking, and biological activity of antimetabolites based on uracils and 5-substituted 2,6-dimethylpyrimidin-4(3H)-ones. Russ. J. Org. Chem. 59(9), 1511\u20131522. https:\/\/doi.org\/10.1134\/S1070428023090087 (2023).","journal-title":"Russ. J. Org. Chem."},{"key":"23237_CR15","first-page":"108","volume":"27","author":"RG Melik-Ogandzhanyan","year":"1979","unstructured":"Melik-Ogandzhanyan, R. G. et al. Synthesis and antitumor activity of some N1-substituted 5-fluorouracils. Khimioter. Opukholei SSSR. 27, 108\u2013112 (1979).","journal-title":"Khimioter. Opukholei SSSR"},{"key":"23237_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1134\/S1070428016010140","volume":"52","author":"AA Harutyunyan","year":"2016","unstructured":"Harutyunyan, A. A. N-(4-Methoxy-3-nitrobenzyl) derivatives of some nitrogen-containing heterocycles. Russ J. Org. Chem. 52, 76\u201379. https:\/\/doi.org\/10.1134\/S1070428016010140 (2016).","journal-title":"Russ J. Org. Chem."},{"key":"23237_CR17","first-page":"45","volume":"10","author":"J Lichtenberger","year":"1953","unstructured":"Lichtenberger, J., Muller, P. & Huguet, M. Halogeno-alkylation. Chloromethylation of fluorobenzene. Bull. Soc. Chim. Fr. 10, 45\u201346 (1953).","journal-title":"Bull. Soc. Chim. Fr."},{"issue":"3A","key":"23237_CR18","first-page":"1457","volume":"18","author":"J Shibata","year":"1998","unstructured":"Shibata, J., Aiba, K., Shibata, H., Minowa, S. & Horikoshi, N. Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR. Anticancer Res. 18 (3A), 1457\u20131463 (1998).","journal-title":"Anticancer Res."},{"key":"23237_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","volume":"237","author":"RB Diasio","year":"1989","unstructured":"Diasio, R. B. & Harris, B. E. Clinical Pharmacology of 5-fluorouracil. Clin. Pharmacokinet. 237, 215\u2013237. https:\/\/doi.org\/10.2165\/00003088-198916040-00002 (1989).","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"23237_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/molecules28020776","volume":"28","author":"J Dulsat","year":"2023","unstructured":"Dulsat, J., L\u00f3pez-Nieto, B., Estrada-Tejedor, R. & Borrell, J. I. Evaluation of free online ADMET tools for academic or small biotech environments. Molecules 28 (2), 776. https:\/\/doi.org\/10.3390\/molecules28020776 (2023).","journal-title":"Molecules"},{"issue":"Database issue","key":"23237_CR21","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. et al. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36(Database issue), D901\u2013D906. https:\/\/doi.org\/10.1093\/nar\/gkm958 (2008).","journal-title":"Nucleic Acids Res."},{"key":"23237_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-008055232-3.61123-7","volume-title":"xPharm: The Comprehensive Pharmacology Reference","author":"BJ Rider","year":"2007","unstructured":"Rider, B. J. 5 Fluorouracil. In xPharm: The Comprehensive Pharmacology Reference (eds Enna, S. J. & Bylund, D. B.) 1\u20135 (Elsevier, 2007). https:\/\/doi.org\/10.1016\/B978-008055232-3.61123-7."},{"issue":"26","key":"23237_CR23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2174\/1568026619666181130140350","volume":"18","author":"H Pham-The","year":"2018","unstructured":"Pham-The, H. et al. In Silico assessment of ADME properties: advances in Caco-2 cell monolayer permeability modeling. Curr. Top. Med. Chem. 18 (26), 2209\u20132229. https:\/\/doi.org\/10.2174\/1568026619666181130140350 (2018).","journal-title":"Curr. Top. Med. Chem."},{"key":"23237_CR24","doi-asserted-by":"publisher","first-page":"102155","DOI":"10.1016\/j.jddst.2020.102155","volume":"61","author":"BE Oliveira","year":"2021","unstructured":"Oliveira, B. E. et al. 5-Fluorouracil: innovative drug delivery systems to enhance bioavailability for topical use. J. Drug Deliv Sci. Technol. 61, 102155. https:\/\/doi.org\/10.1016\/j.jddst.2020.102155 (2021).","journal-title":"J. Drug Deliv Sci. Technol."},{"issue":"1\u20132","key":"23237_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0378-5173(95)04331-4","volume":"129","author":"A Buur","year":"1996","unstructured":"Buur, A., Trier, L., Magnusson, C. & Artursson, P. Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers. Int. J. Pharm. 129 (1\u20132), 223\u2013231. https:\/\/doi.org\/10.1016\/0378-5173(95)04331-4 (1996).","journal-title":"Int. J. Pharm."},{"issue":"1","key":"23237_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1345\/aph.18425","volume":"34","author":"NA Pirzada","year":"2000","unstructured":"Pirzada, N. A., Ali, I. I. & Dafer, R. M. Fluorouracil-induced neurotoxicity. Ann. Pharmacother. 34 (1), 35\u201338. https:\/\/doi.org\/10.1345\/aph.18425 (2000).","journal-title":"Ann. Pharmacother"},{"key":"23237_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.fct.2014.01.026","volume":"66","author":"S Rashid","year":"2014","unstructured":"Rashid, S., Ali, N., Nafees, S., Hasan, S. K. & Sultana, S. Mitigation of 5-fluorouracil-induced renal toxicity by Chrysin via targeting oxidative stress and apoptosis in Wistar rats. Food Chem. Toxicol. 66, 185\u2013193. https:\/\/doi.org\/10.1016\/j.fct.2014.01.026 (2014).","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"23237_CR28","first-page":"1321","volume":"46","author":"BY Shang","year":"2011","unstructured":"Shang, B. Y., Shang, Y., Zhen, Y. S. & Chen, S. Z. Lidamycin inhibits the proliferation of HERG K\u2009+\u2009channel highly expressing cancer cells and shows synergy with anticancer drugs. Yao Xue Xue Bao 46(11), 1321\u20131325 (2011). PMID: 22260022.","journal-title":"Yao Xue Xue Bao"},{"key":"23237_CR29","volume-title":"Holland-Frei Cancer Medicine","author":"SR Rheingold","year":"2003","unstructured":"Rheingold, S. R. et al. Therapy-related secondary cancers. In Holland-Frei Cancer Medicine 6th edn (eds Kufe, D. W. et al.) (BC Decker, 2003).","edition":"6"},{"key":"23237_CR30","unstructured":"ICH. Safety Guidelines. (2024). https:\/\/www.ich.org\/page\/safety-guidelines"},{"issue":"2","key":"23237_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/030089169007600205","volume":"76","author":"A Cavaliere","year":"1990","unstructured":"Cavaliere, A., Alberti, P. F. & Vitali, R. 5-Fluorouracil carcinogenesis in BALB\/c mice. Tumori 76 (2), 179\u2013181. https:\/\/doi.org\/10.1177\/030089169007600205 (1990).","journal-title":"Tumori"},{"issue":"2\u20133","key":"23237_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0278-6915(99)00149-0","volume":"38","author":"K Toyoda","year":"2000","unstructured":"Toyoda, K. et al. Lack of carcinogenicity and increased survival in F344 rats treated with 5-fluorouracil for 2 years. Food Chem. Toxicol. 38 (2\u20133), 187\u2013193. https:\/\/doi.org\/10.1016\/s0278-6915(99)00149-0 (2000).","journal-title":"Food Chem. Toxicol."},{"issue":"Suppl 9","key":"23237_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/em.2860090602","volume":"9","author":"E Zeiger","year":"1987","unstructured":"Zeiger, E. et al. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mutagen. 9 (Suppl 9), 1\u2013109 (1987).","journal-title":"Environ. Mutagen."},{"issue":"5","key":"23237_CR34","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","volume":"51","author":"DJ Giard","year":"1973","unstructured":"Giard, D. J. et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 51(5), 1417\u201323. https:\/\/doi.org\/10.1093\/jnci\/51.5.1417 (1973). PMID: 4357758.","journal-title":"J Natl Cancer Inst."},{"issue":"59","key":"23237_CR35","doi-asserted-by":"publisher","first-page":"99801","DOI":"10.18632\/oncotarget.21068","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Tumor-associated macrophages promote tumor metastasis via the TGF-\u03b2\/SOX9 axis in non-small cell lung cancer. Oncotarget 8(59), 99801\u201399815. https:\/\/doi.org\/10.18632\/oncotarget.21068 (2017). Erratum in: Oncotarget. 2020 Dec 29;11(52):4845\u20134846. doi: 10.18632\/oncotarget.27740. PMID: 29245941; PMCID: PMC5725132.","journal-title":"Oncotarget"},{"key":"23237_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tiv.2017.06.022","volume":"44","author":"DD Wang","year":"2017","unstructured":"Wang, D. D. et al. Induction of CYP1A1 increases gefitinib-induced oxidative stress and apoptosis in A549 cells. Toxicol In Vitro. 44, 36\u201343. https:\/\/doi.org\/10.1016\/j.tiv.2017.06.022 (2017). PMID: 28652202.","journal-title":"Toxicol In Vitro."},{"key":"23237_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/01902140490517818","volume":"30","author":"T Ishii","year":"2004","unstructured":"Ishii, T., Matsuse, T., Masuda, M. & Teramoto, S. The effects of S-phase kinase-associated protein 2 (SKP2) on cell cycle status, viability, and chemoresistance in A549 lung adenocarcinoma cells. Exp. Lung Res. 30, 687\u2013703 (2004).","journal-title":"Exp. Lung Res."},{"issue":"2","key":"23237_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jbt.20010","volume":"18","author":"PL Sheets","year":"2004","unstructured":"Sheets, P. L., Yost, G. S. & Carlson, G. P. Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1. J Biochem Mol Toxicol. 18(2), 92\u20139. https:\/\/doi.org\/10.1002\/jbt.20010 (2004). PMID: 15122651.","journal-title":"J Biochem Mol Toxicol."},{"key":"23237_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"HF Chang","year":"2019","unstructured":"Chang, H. F. et al. Doxycycline inhibits electric field-induced migration of non-small cell lung cancer (NSCLC) cells. Sci. Rep. 9, 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"23237_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep03169","volume":"3","author":"LY Lu","year":"2013","unstructured":"Lu, L. Y., Ou, N. & Lu, Q. Bin antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci. Rep. 3, 1\u201311 (2013).","journal-title":"Sci. Rep."},{"key":"23237_CR41","doi-asserted-by":"publisher","first-page":"108855","DOI":"10.1016\/j.biopha.2019.108855","volume":"114","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S., Pal, A. & Ray, M. Methylglyoxal in combination with 5-fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle Inhibition. Biomed. Pharmacol. 114, 108855. https:\/\/doi.org\/10.1016\/j.biopha.2019.108855 (2019).","journal-title":"Biomed. Pharmacol."},{"issue":"4","key":"23237_CR42","doi-asserted-by":"publisher","first-page":"rqad034","DOI":"10.1093\/rpsppr\/rqad034","volume":"2","author":"ME Elbanan","year":"2023","unstructured":"Elbanan, M. E. et al. Melatonin protects mice from 5-FU hepatotoxicity and improves 5-FU antitumor effects by an apoptotic pathway dependent on cell cycle arrest in A549 human lung cancer cells. RPS Pharm. Pharmacol. Rep. 2 (4), rqad034. https:\/\/doi.org\/10.1093\/rpsppr\/rqad034 (2023).","journal-title":"RPS Pharm. Pharmacol. Rep."},{"issue":"2","key":"23237_CR43","doi-asserted-by":"publisher","first-page":"e56679","DOI":"10.1371\/journal.pone.0056679","volume":"8","author":"X Pan","year":"2013","unstructured":"Pan, X. et al. Autophagy Inhibition promotes 5-fluorouracil-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS One. 8 (2), e56679. https:\/\/doi.org\/10.1371\/journal.pone.0056679 (2013).","journal-title":"PLoS One"},{"key":"23237_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/10717544.2016.1264499","volume":"24(1)","author":"C Huang","year":"2017","unstructured":"Huang, C. et al. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy. Drug Deliv. 24(1), 459\u2013466. https:\/\/doi.org\/10.1080\/10717544.2016.1264499 (2017).","journal-title":"Drug Deliv"},{"issue":"1","key":"23237_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/biomedicines10010041","volume":"10","author":"E Burgos-Mor\u00f3n","year":"2021","unstructured":"Burgos-Mor\u00f3n, E. et al. In vitro anticancer activity and mechanism of action of an Aziridinyl Galactopyranoside. Biomedicines 10 (1), 41. https:\/\/doi.org\/10.3390\/biomedicines10010041 (2021).","journal-title":"Biomedicines"},{"key":"23237_CR46","doi-asserted-by":"publisher","first-page":"zqae008","DOI":"10.1093\/function\/zqae008","volume":"5","author":"S Nath","year":"2024","unstructured":"Nath, S. & Balling, R. The Warburg effect reinterpreted 100 years on: a first-principles stoichiometric analysis and interpretation from the perspective of ATP metabolism in cancer cells. Function 5, zqae008 (2024).","journal-title":"Function"},{"key":"23237_CR47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng, J. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (review). Oncol. Lett. 4, 1151\u20131157 (2012).","journal-title":"Oncol. Lett."},{"key":"23237_CR48","doi-asserted-by":"publisher","first-page":"42740","DOI":"10.18632\/oncotarget.8600","volume":"7","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Cancer drug resistance: redox resetting renders a way. Oncotarget 7, 42740\u201342761 (2016).","journal-title":"Oncotarget"},{"issue":"2","key":"23237_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell. 38 (2), 167\u2013197. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001 (2020).","journal-title":"Cancer Cell."},{"key":"23237_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","volume":"142","author":"B Halliwell","year":"2004","unstructured":"Halliwell, B. & Whiteman, M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142, 231\u2013255 (2004).","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"23237_CR51","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nbt899","volume":"21","author":"WR Zipfel","year":"2003","unstructured":"Zipfel, W. R., Williams, R. M. & Webb, W. W. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol. 21(11), 1369\u201377. https:\/\/doi.org\/10.1038\/nbt899 (2003). PMID: 14595365.","journal-title":"Nat Biotechnol."},{"issue":"2","key":"23237_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.vascn.2010.10.004","volume":"63","author":"C Sanmart\u00edn-Su\u00e1rez","year":"2011","unstructured":"Sanmart\u00edn-Su\u00e1rez, C. et al. Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants. J. Pharm. Toxicol. Methods. 63 (2), 209\u2013215. https:\/\/doi.org\/10.1016\/j.vascn.2010.10.004 (2011).","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"1\u20132","key":"23237_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2011.12.012","volume":"327","author":"EI Azzam","year":"2012","unstructured":"Azzam, E. I., Jay-Gerin, J. P. & Pain, D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 327(1\u20132), 48\u201360. https:\/\/doi.org\/10.1016\/j.canlet.2011.12.012 (2012).","journal-title":"Cancer Lett."},{"key":"23237_CR54","doi-asserted-by":"publisher","unstructured":"Reisz, J. A., et al. Effects of ionizing radiation on biological molecules\u2014mechanisms of damage and emerging methods of detection.  Antioxid. Redox Signal. 21(2), 260\u2013292. https:\/\/doi.org\/10.1089\/ars.2013.5489 (2014).","DOI":"10.1089\/ars.2013.5489"},{"issue":"5","key":"23237_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5483\/bmbrep.2005.38.5.533","volume":"38","author":"J Hong","year":"2005","unstructured":"Hong, J. et al.Thermal dissociation and conformational lock of superoxide dismutase. J. Biochem. Mol. Biol. 38(5), 533\u2013538. https:\/\/doi.org\/10.5483\/bmbrep.2005.38.5.533 (2005).","journal-title":"J. Biochem. Mol. Biol."},{"issue":"51","key":"23237_CR56","doi-asserted-by":"publisher","first-page":"19683","DOI":"10.1074\/jbc.REV119.006217","volume":"294","author":"CL Hawkins","year":"2019","unstructured":"Hawkins, C. L. & Davies, M. J. Detection, identification, and quantification of oxidative protein modifications. J. Biol. Chem. 294 (51), 19683\u201319708. https:\/\/doi.org\/10.1074\/jbc.REV119.006217 (2019).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"23237_CR57","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.3390\/ijms25063404","volume":"25","author":"ES Lin","year":"2024","unstructured":"Lin, E. S. & Huang, C. Y. Binding pattern and structural interactome of the anticancer drug 5-fluorouracil: A critical review. Int. J. Mol. Sci. 25 (6), 3404. https:\/\/doi.org\/10.3390\/ijms25063404 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"23237_CR58","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.tig.2023.08.004","volume":"39","author":"MA Vittoria","year":"2023","unstructured":"Vittoria, M. A., Quinton, R. J. & Ganem, N. J. Whole-genome doubling in tissues and tumors. Trends Genet. 39 (12), 954\u2013967. https:\/\/doi.org\/10.1016\/j.tig.2023.08.004 (2023).","journal-title":"Trends Genet."},{"key":"23237_CR59","doi-asserted-by":"publisher","first-page":"131706","DOI":"10.1016\/j.ijbiomac.2024.131706","volume":"268(Pt 1)","author":"S Ghosh","year":"2024","unstructured":"Ghosh, S. et al. Characterization of polyploidy in cancer: current status and future perspectives. Int. J. Biol. Macromol. 268(Pt 1), 131706. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131706 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"23237_CR60","doi-asserted-by":"publisher","first-page":"960317","DOI":"10.3389\/fonc.2022.960317","volume":"12","author":"CM Tilsed","year":"2022","unstructured":"Tilsed, C. M. et al. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front. Oncol. 12, 960317. https:\/\/doi.org\/10.3389\/fonc.2022.960317 (2022).","journal-title":"Front. Oncol."},{"issue":"13","key":"23237_CR61","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.3390\/ijms22136923","volume":"22","author":"Y Sun","year":"2021","unstructured":"Sun, Y., Liu, Y., Ma, X. & Hu, H. The influence of cell cycle regulation on chemotherapy. Int. J. Mol. Sci. 22(13), 6923. https:\/\/doi.org\/10.3390\/ijms22136923 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"23237_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2021.03.003","volume":"81","author":"H Was","year":"2022","unstructured":"Was, H. et al. Polyploidy formation in cancer cells: how a Trojan horse is born. Semin Cancer Biol. 81, 24\u201336 (2022).","journal-title":"Semin Cancer Biol."},{"issue":"7781","key":"23237_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575 (7781), 210\u2013216. https:\/\/doi.org\/10.1038\/s41586-019-1689-y (2019).","journal-title":"Nature"},{"key":"23237_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fct.2017.10.056","volume":"111","author":"M Milczarek","year":"2018","unstructured":"Milczarek, M. et al. Autophagic cell death and premature senescence: new mechanism of 5-fluorouracil and Sulforaphane synergistic anticancer effect in MDA-MB-231 triple negative breast cancer cell line. Food Chem. Toxicol. 111, 1\u20138. https:\/\/doi.org\/10.1016\/j.fct.2017.10.056 (2018).","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"23237_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/1319-3767.199136","volume":"23","author":"R Hamam","year":"2017","unstructured":"Hamam, R. et al. Enhanced efficacy of 5-fluorouracil in combination with a dual histone deacetylase and phosphatidylinositide 3-kinase inhibitor (CUDC-907) in colorectal cancer cells. Saudi J. Gastroenterol. 23 (1), 34\u201338. https:\/\/doi.org\/10.4103\/1319-3767.199136 (2017).","journal-title":"Saudi J. Gastroenterol."},{"issue":"1","key":"23237_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/15384047.2017.1385675","volume":"19","author":"H Was","year":"2018","unstructured":"Was, H. et al. Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features. Cancer Biol. Ther. 19 (1), 63\u201375. https:\/\/doi.org\/10.1080\/15384047.2017.1385675 (2018).","journal-title":"Cancer Biol. Ther."},{"key":"23237_CR67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1590\/S1415-47572000000100020","volume":"23","author":"SS Maria","year":"2000","unstructured":"Maria, S. S., Vidal, B. & de Mello, C. Image analysis of DNA fragmentation and loss in V79 cells under apoptosis. Genet. Mol. Biol. 23, 109\u2013112. https:\/\/doi.org\/10.1590\/S1415-47572000000100020 (2000).","journal-title":"Genet. Mol. Biol."},{"key":"23237_CR68","first-page":"1411","volume":"196","author":"R Quelet","year":"1933","unstructured":"Quelet, R. The synthesis of chloromethylated derivatives of p-bromoanisole and the nitroanisoles. Compt Rend. 196, 1411\u20131413 (1933).","journal-title":"Compt Rend."},{"key":"23237_CR69","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/bscb.19800890607","volume":"89","author":"R Verhe","year":"1980","unstructured":"Verhe, R. et al. Preparation of synthetic rotenoids. Bull. Soc. Chim. Belg. 89, 459\u2013485. https:\/\/doi.org\/10.1002\/bscb.19800890607 (1980).","journal-title":"Bull. Soc. Chim. Belg."},{"key":"23237_CR70","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9, 676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019 (2012).","journal-title":"Nat. Methods"},{"key":"23237_CR71","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0014-4827(75)90386-9","volume":"92","author":"J Gaub","year":"1975","unstructured":"Gaub, J., Auer, G. & Zetterberg, A. Quantitative cytochemical aspects of a combined Feulgen-Naphthol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp. Cell. Res. 92, 323\u2013332. https:\/\/doi.org\/10.1016\/0014-4827(75)90386-9 (1975).","journal-title":"Exp. Cell. Res."},{"key":"23237_CR72","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1369\/0022155417749490","volume":"66","author":"ZA Karalyan","year":"2018","unstructured":"Karalyan, Z. A. et al. Evaluation of viral genome copies within viral factories on different DNA viruses. J. Histochem. Cytochem. 66, 359\u2013365 (2018).","journal-title":"J. Histochem. Cytochem."},{"key":"23237_CR73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00133246","volume":"2","author":"B Lassalle","year":"1989","unstructured":"Lassalle, B., Gautron, J., Martelly, I. & Le Moigne, A. Image analysis of rat satellite cell proliferation in vitro. Cytotechnology 2, 213\u2013224 (1989).","journal-title":"Cytotechnology"},{"issue":"3","key":"23237_CR74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1155\/1997\/935728","volume":"15","author":"G Haroske","year":"1997","unstructured":"Haroske, G., Dimmer, V., Meyer, W. & Kunze, K. D. DNA histogram interpretation based on statistical approaches. Anal. Cell. Pathol. 15 (3), 157\u2013173. https:\/\/doi.org\/10.1155\/1997\/935728 (1997).","journal-title":"Anal. Cell. Pathol."},{"issue":"10","key":"23237_CR75","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra, H. P. & Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247(10), 3170\u20135 (1972) (PMID: 4623845).","journal-title":"J Biol Chem."},{"key":"23237_CR76","first-page":"674","volume":"2","author":"TV Sirota","year":"1999","unstructured":"Sirota, T. V. Method for the determination of antioxidant activity of superoxide dismutase and chemical compounds. Russian Federation Patent. 2, 144,674 (1999).","journal-title":"Russian Federation Patent"},{"key":"23237_CR77","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1134\/S1990750817020068","volume":"11","author":"TV Sirota","year":"2017","unstructured":"Sirota, T. V. Standardization and regulation of the rate of the superoxide-generating reaction of adrenaline autoxidation used for evaluation of pro\/antioxidant properties of various materials. Biochem. Mosc. Suppl. Ser. B. 11, 128\u2013133. https:\/\/doi.org\/10.1134\/S1990750817020068 (2017).","journal-title":"Biochem. Mosc. Suppl. Ser. B"},{"issue":"2\u20133","key":"23237_CR78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(91)90067-m","volume":"196","author":"L G\u00f3th","year":"1991","unstructured":"G\u00f3th, L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 196(2\u20133), 143\u201351. https:\/\/doi.org\/10.1016\/0009-8981(91)90067-m (1991). PMID: 2029780.","journal-title":"Clin Chim Acta."},{"key":"23237_CR79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0021-9258(19)50881-X","volume":"195","author":"RF Beers Jr","year":"1952","unstructured":"Beers, R. F. Jr. & Sizer, I. W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195, 133\u2013140 (1952).","journal-title":"J. Biol. Chem."},{"key":"23237_CR80","doi-asserted-by":"publisher","unstructured":"OECD. Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models. OECD Series on Testing and Assessment, No. 69. OECD Publishing, Paris. (2014). https:\/\/doi.org\/10.1787\/9789264085442-en","DOI":"10.1787\/9789264085442-en"},{"key":"23237_CR81","unstructured":"Landrum, G. Rdkit: Open-Source Cheminformatics Software. Retrieved from https:\/\/github.com\/rdkit (2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23237-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T07:06:19Z","timestamp":1763363179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23237-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23237"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23237-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39689"}}